The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. To ...
Colgate-Palmolive forecast 2025 sales to be roughly flat from last year; sales came in at $20.10 billion in 2024. Write to Denny Jacob at denny.jacob@wsj.com ...
Pet King Brands, the Austin-local leader of veterinarian-recommended enzymatic pet health care and creator of the award-winning ZYMOX, is honored to announce their recognition in the "2025 Editor's ...